| 1 | LLY | Eli Lilly and Company | $1.04T | 39.1 | 0.5% |
| 2 | JNJ | Johnson & Johnson | $626.01B | 30.1 | 2.0% |
| 3 | ABBV | AbbVie Inc | $439.97B | 70.3 | 2.0% |
| 4 | UNH | UnitedHealth Group Incorporated | $361.22B | 30.0 | 2.2% |
| 5 | MRK | Merck & Company Inc | $328.21B | 106.5 | 2.5% |
| 6 | NVS | Novartis AG ADR | $287.36B | 22.9 | 3.1% |
| 7 | AZN | AstraZeneca PLC | $242.97B | 23.5 | 2.7% |
| 8 | AMGN | Amgen Inc | $222.66B | 25.6 | 2.4% |
| 9 | TMO | Thermo Fisher Scientific Inc | $218.35B | 31.8 | 0.3% |
| 10 | NVO | Novo Nordisk A/S | $204.55B | 11.4 | 3.9% |
| 11 | ABT | Abbott Laboratories | $192.35B | 35.7 | 1.7% |
| 12 | GILD | Gilead Sciences Inc | $171.48B | — | 1.7% |
| 13 | PFE | Pfizer Inc | $151.09B | 34.9 | 4.8% |
| 14 | DHR | Danaher Corporation | $140.31B | 35.6 | 0.5% |
| 15 | ISRG | Intuitive Surgical Inc | $138.44B | 44.4 | — |
| 16 | BMY | Bristol-Myers Squibb Company | $131.77B | 14.2 | 2.9% |
| 17 | SYK | Stryker Corporation | $128.32B | 34.6 | 0.8% |
| 18 | VRTX | Vertex Pharmaceuticals Inc | $123.94B | 28.5 | — |
| 19 | CVS | CVS Health Corp | $121.60B | 25.1 | 2.1% |
| 20 | MDT | Medtronic PLC | $110.76B | 23.7 | 2.4% |
| 21 | SNY | Sanofi ADR | $104.85B | 23.4 | 5.5% |
| 22 | GSK | GlaxoSmithKline PLC ADR | $102.57B | 16.2 | 3.4% |
| 23 | MCK | McKesson Corporation | $98.78B | 22.7 | 0.4% |
| 24 | HCA | HCA Healthcare, Inc. | $88.96B | 13.8 | 0.5% |
| 25 | ELV | Elevance Health Inc | $85.60B | 17.4 | 1.7% |
| 26 | REGN | Regeneron Pharmaceuticals Inc | $80.55B | 19.4 | 0.4% |
| 27 | CI | Cigna Corp | $74.57B | 11.7 | 2.2% |
| 28 | BSX | Boston Scientific Corp | $73.25B | 20.5 | — |
| 29 | COR | Cencora Inc. | $58.34B | 22.7 | 0.8% |
| 30 | TAK | Takeda Pharmaceutical Co Ltd ADR | $55.20B | — | 1.8% |
| 31 | CAH | Cardinal Health Inc | $53.95B | 35.2 | 0.7% |
| 32 | ARGX | argenx NV ADR | $53.23B | 32.7 | — |
| 33 | EW | Edwards Lifesciences Corp | $51.99B | 53.7 | — |
| 34 | MDLN | Medline Inc. Class A Common Stock | $49.88B | 46.4 | — |
| 35 | BDX | Becton Dickinson and Company | $48.80B | 31.0 | 2.1% |
| 36 | NTRA | Natera Inc | $45.32B | — | — |
| 37 | HUM | Humana Inc | $44.02B | 34.3 | 0.7% |
| 38 | IDXX | IDEXX Laboratories Inc | $43.98B | 39.2 | — |
| 39 | HLN | Haleon plc | $43.55B | 20.2 | 1.9% |
| 40 | RVMD | Revolution Medicines Inc | $42.92B | — | — |
| 41 | TEVA | Teva Pharma Industries Ltd ADR | $41.60B | 59.5 | — |
| 42 | A | Agilent Technologies Inc | $41.39B | 148.0 | 0.5% |
| 43 | VEEV | Veeva Systems Inc Class A | $40.30B | 43.9 | — |
| 44 | WAT | Waters Corporation | $40.13B | 103.2 | — |
| 45 | IQV | IQVIA Holdings Inc | $39.22B | 28.9 | — |
| 46 | ONC | BeiGene, Ltd. | $39.07B | 61.6 | — |
| 47 | ALC | Alcon AG | $34.96B | 42.9 | 1.1% |
| 48 | DXCM | DexCom Inc | $33.38B | 35.0 | — |
| 49 | RPRX | Royalty Pharma Plc | $33.14B | 30.8 | 1.6% |
| 50 | GEHC | GE HealthCare Technologies Inc. | $32.80B | 16.7 | 0.1% |
| 51 | CNC | Centene Corp | $32.24B | — | — |
| 52 | RMD | ResMed Inc | $31.68B | 20.9 | 1.1% |
| 53 | BIIB | Biogen Inc | $31.25B | 37.5 | — |
| 54 | ALNY | Alnylam Pharmaceuticals Inc | $30.70B | 40.0 | — |
| 55 | ZTS | Zoetis Inc | $30.42B | 12.0 | 2.1% |
| 56 | MTD | Mettler-Toledo International Inc | $28.70B | 32.3 | — |
| 57 | ILMN | Illumina Inc | $28.51B | 35.2 | — |
| 58 | INSM | Insmed Inc | $26.84B | — | — |
| 59 | ROIV | Roivant Sciences Ltd | $26.62B | — | — |
| 60 | PHG | Koninklijke Philips NV ADR | $26.55B | 20.6 | 3.7% |
| 61 | DGX | Quest Diagnostics Incorporated | $26.14B | 25.2 | 1.0% |
| 62 | LH | Laboratory Corporation of America Holdings | $26.01B | 26.5 | 0.9% |
| 63 | MRNA | Moderna Inc | $25.14B | — | — |
| 64 | WST | West Pharmaceutical Services Inc | $24.49B | 43.9 | 0.2% |
| 65 | INCY | Incyte Corporation | $24.23B | 15.2 | — |
| 66 | BNTX | BioNTech SE | $23.36B | — | — |
| 67 | STE | STERIS plc | $22.86B | 28.7 | 1.1% |
| 68 | UTHR | United Therapeutics Corporation | $21.87B | 18.3 | — |
| 69 | THC | Tenet Healthcare Corporation | $21.70B | 10.4 | — |
| 70 | GH | Guardant Health Inc | $21.57B | — | — |
| 71 | GMAB | Genmab AS | $19.78B | 25.0 | — |
| 72 | ZBH | Zimmer Biomet Holdings Inc | $18.76B | 23.9 | 0.7% |
| 73 | VTRS | Viatris Inc | $18.59B | — | 3.0% |
| 74 | ASND | Ascendis Pharma AS | $16.14B | 28.1 | — |
| 75 | JAZZ | Jazz Pharmaceuticals PLC | $15.96B | 16.8 | — |
| 76 | MEDP | Medpace Holdings Inc | $15.93B | 33.6 | — |
| 77 | BBIO | BridgeBio Pharma Inc | $15.87B | — | — |
| 78 | NBIX | Neurocrine Biosciences Inc | $15.19B | 21.8 | — |
| 79 | COO | The Cooper Companies, Inc | $14.65B | 63.1 | — |
| 80 | SOLV | Solventum Corp. | $14.34B | 10.3 | — |
| 81 | BAX | Baxter International Inc | $13.86B | — | 0.1% |
| 82 | CRL | Charles River Laboratories | $12.97B | — | — |
| 83 | RVTY | Revvity Inc. | $12.94B | 55.8 | 0.2% |
| 84 | PEN | Penumbra Inc | $12.82B | 80.2 | — |
| 85 | EXEL | Exelixis Inc | $12.80B | 16.3 | — |
| 86 | ICLR | ICON PLC | $12.80B | 251.4 | — |
| 87 | SNN | Smith & Nephew SNATS Inc | $12.63B | 20.5 | 2.6% |
| 88 | FMS | Fresenius Medical Care Corporation | $12.54B | 12.3 | 3.7% |
| 89 | ALGN | Align Technology Inc | $12.35B | 30.2 | — |
| 90 | BMRN | Biomarin Pharmaceutical Inc | $12.29B | 171.6 | — |
| 91 | EHC | Encompass Health Corp | $12.19B | 20.5 | 0.5% |
| 92 | BTSG | BrightSpring Health Services, Inc. Common Stock | $12.11B | 54.6 | — |
| 93 | HALO | Halozyme Therapeutics Inc | $12.00B | 29.7 | — |
| 94 | ARWR | Arrowhead Pharmaceuticals Inc | $12.00B | — | — |
| 95 | MDGL | Madrigal Pharmaceuticals Inc | $11.60B | — | — |
| 96 | CORT | Corcept Therapeutics Incorporated | $11.58B | 238.1 | — |
| 97 | DVA | DaVita HealthCare Partners Inc | $11.43B | 15.2 | — |
| 98 | TECH | Bio-Techne Corp | $11.27B | 103.3 | 0.4% |
| 99 | ELAN | Elanco Animal Health | $11.15B | — | — |
| 100 | GMED | Globus Medical | $11.15B | 21.0 | — |